Is it time for more pediatric billing transparency in vaccine costs?
Hemant Apte, Chief Executive OfficerNovember 19, 2025
Parental skepticism of pediatric vaccines is growing. One of the reasons is that some parents question the profit motive of pharmaceutical companies [1], leaving pediatricians caught in the middle. Anyone familiar with pediatric billing and coding knows the truth – there’s little money for physicians to make in pediatric vaccines. In reality, physicians often lose money when protecting the health of children.
Take the HPV vaccine, for example. A 2023 study found that net returns were as low as $0.34/dose for family physicians and at their highest, only reached $5.08/dose for pediatricians [2]. These are not rates that drive doctors to vaccinate children unnecessarily. Some physicians even lose money on their vaccine programs. A Virginia pediatrician recently reported to MedCity News that he spends about half a million dollars every year on vaccines, and possibly isn’t even breaking even [3].
Vaccines are the second-highest expense for pediatric practices, coming in second only to staff salaries. In addition to the effort of getting reimbursed for vaccines through pediatric medical billing, many physicians are simply absorbing the costs and risks just to maintain their childhood vaccination programs.
Turning Pediatric Billing Hesitancy Into an Asset
While there is a need for multiple types of education to address parental vaccine hesitancy, pediatric billing leaders could have an opportunity to add their voice to the discussion. Transparency in billing and creativity in pediatric billing communications can be a first step in not only helping parents and guardians make informed decisions about vaccination but also function as a powerful tool in building trust and sparking a deeper conversation about children’s health.
Improved communication and awareness are especially important this flu season, where pediatric flu deaths have reached their highest rate since the 2009-10 H1N1 pandemic [4]. More children are presenting with conditions associated with the flu, like acute necrotizing encephalopathy (ANE). At the same time, hesitancy is as high as 56% for COVID vaccines and 12% for routine childhood vaccinations [5].
The American Academy of Pediatrics offers some guidance on talking with vaccine hesitant parents [6]. Use these as a starting point and guide rails for educating parents on the lack of profitability in pediatric vaccines for providers.
To learn more about how you can bring your pediatric billing strategy up to date with current challenges or how to strengthen your pediatric billing and coding workflows, feel free to message me here, or connect with one of our experienced team members.
[1] U. Uğrak, A. Aksungur, S. Akyüz, H. Şen and F. Seyhan, "Understanding the rise of vaccine refusal: perceptions, fears, and influences," BMC Public Health, 29 July 2025. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC12306073/.
[2] Y. Zhu, Y.-Y. Lin, R. Li, C. He, D. R. Lairson, A. A. Deshmukh and K. Sonawane, "Reimbursement for HPV Vaccine Cost in the Private Sector: A Comparison Across Specialties," Ann Fam Med, Jul-Aug 2023. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC10365861/.
[3] P. Sánchez de Lozada, "Pediatricians Subsidize the Vaccinations That Keep Kids Healthy and Prevent Pandemics. They Shouldn’t Have To," MedCity News, 10 August 2025. Available: https://medcitynews.com/2025/08/pediatricians-subsidize-the-vaccinations-that-keep-kids-healthy-and-prevent-pandemics-they-shouldnt-have-to/.
[4] E. Edwards, "More kids are severely ill or dying from the flu, CDC reports," NBC News, 25 September 2025. Available: https://www.nbcnews.com/health/health-news/flu-vaccines-children-complication-cdc-deaths-rcna233436.
[5] J. Wappes, "CDC analysis shows high rate of parental hesitation toward kids' vaccinations," CIDRAP - Center for Infectious Disease Research & Policy, 17 July 2024. Available: https://www.cidrap.umn.edu/childhood-vaccines/cdc-analysis-shows-high-rate-parental-hesitation-toward-kids-vaccinations.
[6] American Academy of Pediatrics, "Talking with Vaccine Hesitant Parents," 9 October 2025. Available: https://www.aap.org/en/patient-care/immunizations/communicating-with-families-and-promoting-vaccine-confidence/talking-with-vaccine-hesitant-parents/?srsltid=AfmBOoq1xtyeMH9IyvlwnZwVv9OJLQGlgegBy5m2im8Q_Aa7FI6h6umY.
Hemant Apte, Chief Executive Officer
Hemant Apte is the Founder and CEO of 3Gen Consulting, a leading healthcare revenue cycle management and technology company serving providers, ACOs, and health plans across the U.S. Since founding 3Gen in 2006, Hemant has guided the company’s evolution from a boutique consulting firm into a data-driven organization at the forefront of AI-powered RCM innovation. With decades of experience in U.S. healthcare operations, Hemant continues to provide thought leadership to clients navigating financial, compliance, and technology challenges in an increasingly value-based care environment.
Want to Strengthen Your Pediatric Billing Strategy?
Get guidance on workflow gaps, reimbursement challenges and communication strategies that help pediatric practices stay financially sustainable.
Connect with our experts to:
- Improve pediatric billing workflows
- Reduce vaccine-related losses
- Strengthen reimbursement accuracy
Explore our strategic insights & resources
View All ResourcesView All Resources
FAQs
The FAQ section simplifies key information about 3Gen Consulting’s services, helping partners navigate our offerings, methodologies, and value.
Talk to an ExpertTalk to an Expert
Most pediatric practices pay upfront for vaccines, manage storage, track inventory, and absorb wastage – yet payer reimbursement rarely covers the full cost. Studies show net returns as low as $0.34 per HPV dose. Because vaccine reimbursement often lags behind acquisition and administration costs, pediatric billing teams face recurring losses even when workflows are accurate.
Greater transparency around vaccine costs, reimbursement challenges, and pediatric billing processes helps parents understand that physicians don’t profit from vaccines. Clear communication builds trust, counters the belief that vaccination is financially motivated, and supports informed decision-making – especially during high-risk flu seasons.
Common challenges include:
- Inadequate vaccine reimbursement rates
- Payer-specific rules for immunization billing
- Low payment for vaccine administration codes
- Denials tied to eligibility errors
- High upfront cost of purchasing vaccines
- Delays in reimbursement for pediatric services
These issues make pediatric vaccine billing one of the most financially complex parts of the revenue cycle.
Practices can strengthen reimbursement by improving coding accuracy, eligibility verification, denial prevention workflows, and payer-specific authorization checks. Tracking denial trends, appealing underpaid claims, and optimizing immunization administration coding (e.g., correct quantity, modifier use) can significantly reduce loss on vaccines.
Effective communication is essential. When pediatric billing teams clearly explain vaccine costs, coverage limitations, and practice-level financial impact, parents better understand that childhood vaccines are not profit drivers. This transparency supports broader conversations around safety, community health benefits, and timely immunization.
3Gen helps pediatric organizations improve revenue cycle performance with:
- End-to-end pediatric billing optimization
- Vaccine reimbursement analysis
- Coding accuracy reviews for immunizations
- Denial reduction workflows
- Payer rule management and compliance support
This ensures practices remain financially sustainable while continuing to offer comprehensive childhood vaccination programs.